Skip to main content

and
  1. No Access

    Article

    In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia

    To develop a novel gene therapeutic modality for the effective treatment of benign prostatic hyperplasia (BPH), we investigated the properties of toxic gene therapy utilizing prostate-specific antigen (PSA) pr...

    H S Park, J Cheon, H Y Cho, Y H Ko, J H Bae, D G Moon, J J Kim in Gene Therapy (2003)